|
2024-02-20 |
2024-02-16 |
V
Vente
|
Kelly Thomas Patrick
Chief Financial Officer
Dirigeant
|
3 010
-3.6%
15,62
47 009 USD
|
3 010
-3.6%
|
15,62
|
47 009 USD
|
|
|
2024-02-20 |
2024-02-16 |
V
Vente
|
Sherman Matthew L
EVP & Chief Medical Officer
Dirigeant
|
2 615
-2.3%
15,62
40 840 USD
|
2 615
-2.3%
|
15,62
|
40 840 USD
|
|
|
2024-02-20 |
2024-02-16 |
V
Vente
|
Pitman Jama
SVP, Chief Development Officer
Dirigeant
|
2 267
-3.2%
15,62
35 405 USD
|
2 267
-3.2%
|
15,62
|
35 405 USD
|
|
|
2024-02-20 |
2024-02-16 |
V
Vente
|
Martin Daniel C.
Chief Commercial Officer
Dirigeant
|
2 267
-4.0%
15,62
35 405 USD
|
2 267
-4.0%
|
15,62
|
35 405 USD
|
|
|
2024-01-18 |
2024-01-16 |
V
Vente
|
Pitman Jama
SVP, Chief Development Officer
Dirigeant
|
1 624
-3.1%
14,47
23 499 USD
|
1 624
-3.1%
|
14,47
|
23 499 USD
|
|
|
2024-01-18 |
2024-01-16 |
V
Vente
|
Sherman Matthew L
EVP & Chief Medical Officer
Dirigeant
|
2 435
-2.5%
14,47
35 234 USD
|
2 435
-2.5%
|
14,47
|
35 234 USD
|
|
|
2024-01-18 |
2024-01-16 |
V
Vente
|
Kelly Thomas Patrick
Chief Financial Officer
Dirigeant
|
2 435
-3.6%
14,47
35 234 USD
|
2 435
-3.6%
|
14,47
|
35 234 USD
|
|
|
2024-01-18 |
2024-01-16 |
V
Vente
|
Martin Daniel C.
Chief Commercial Officer
Dirigeant
|
1 624
-3.3%
14,47
23 499 USD
|
1 624
-3.3%
|
14,47
|
23 499 USD
|
|
|
2023-12-14 |
2023-12-13 |
V
Vente
|
Kelly Thomas Patrick
Chief Financial Officer
Dirigeant
|
2 792
-3.9%
15,37
42 905 USD
|
2 792
-3.9%
|
15,37
|
42 905 USD
|
|
|
2023-12-14 |
2023-12-13 |
V
Vente
|
Sherman Matthew L
EVP & Chief Medical Officer
Dirigeant
|
2 792
-2.8%
15,37
42 905 USD
|
2 792
-2.8%
|
15,37
|
42 905 USD
|
|
|
2023-12-14 |
2023-12-13 |
V
Vente
|
Pitman Jama
See Remarks
Dirigeant
|
1 662
-3.1%
15,37
25 540 USD
|
1 662
-3.1%
|
15,37
|
25 540 USD
|
|
|
2023-12-14 |
2023-12-13 |
V
Vente
|
Hoerter Steven L.
President and CEO
Administrateur exécutif
|
30 664
-29.6%
15,37
471 217 USD
|
30 664
-29.6%
|
15,37
|
471 217 USD
|
|
|
2023-12-14 |
2023-12-13 |
V
Vente
|
Martin Daniel C.
Chief Commercial Officer
Dirigeant
|
1 727
-3.4%
15,37
26 539 USD
|
1 727
-3.4%
|
15,37
|
26 539 USD
|
|
|
2023-12-01 |
2023-11-30 |
VP
Vente planifiée
|
Martin Daniel C.
Chief Commercial Officer
Dirigeant
|
17 801
-28.2%
12,57
223 755 USD
|
17 801
-28.2%
|
12,57
|
223 755 USD
|
|
|
2023-10-31 |
2023-10-30 |
V
Vente
|
Martin Daniel C.
Chief Commercial Officer
Dirigeant
|
1 407
-2.2%
12,02
16 909 USD
|
1 407
-2.2%
|
12,02
|
16 909 USD
|
|
|
2023-10-31 |
2023-10-30 |
V
Vente
|
Hoerter Steven L.
President and CEO
Administrateur exécutif
|
21 573
-34.5%
12,02
259 256 USD
|
21 573
-34.5%
|
12,02
|
259 256 USD
|
|
|
2023-10-31 |
2023-10-30 |
V
Vente
|
Pitman Jama
See Remarks
Dirigeant
|
1 407
-2.8%
12,02
16 909 USD
|
1 407
-2.8%
|
12,02
|
16 909 USD
|
|
|
2023-10-31 |
2023-10-30 |
V
Vente
|
Sherman Matthew L
EVP & Chief Medical Officer
Dirigeant
|
2 360
-2.5%
12,02
28 362 USD
|
2 360
-2.5%
|
12,02
|
28 362 USD
|
|
|
2023-10-31 |
2023-10-30 |
V
Vente
|
Kelly Thomas Patrick
Chief Financial Officer
Dirigeant
|
2 316
-3.5%
12,02
27 833 USD
|
2 316
-3.5%
|
12,02
|
27 833 USD
|
|
|
2023-10-04 |
2023-10-02 |
V
Vente
|
Sherman Matthew L
EVP & Chief Medical Officer
Dirigeant
|
2 942
-3.4%
12,68
37 305 USD
|
2 942
-3.4%
|
12,68
|
37 305 USD
|
|
|
2023-06-21 |
2023-06-16 |
V
Vente
|
Kelly Thomas Patrick
Chief Financial Officer
Dirigeant
|
1 655
-2.8%
14,40
23 835 USD
|
1 655
-2.8%
|
14,40
|
23 835 USD
|
|
|
2023-06-21 |
2023-06-16 |
VP
Vente planifiée
|
Martin Daniel C.
Chief Commercial Officer
Dirigeant
|
1 238
-2.1%
14,40
17 829 USD
|
1 238
-2.1%
|
14,40
|
17 829 USD
|
|
|
2023-06-21 |
2023-06-16 |
VP
Vente planifiée
|
Sherman Matthew L
EVP & Chief Medical Officer
Dirigeant
|
1 655
-1.9%
14,40
23 835 USD
|
1 655
-1.9%
|
14,40
|
23 835 USD
|
|
|
2023-06-21 |
2023-06-16 |
V
Vente
|
Flynn Daniel Lee
Chief Scientific Officer
Dirigeant
|
1 655
-2.8%
14,40
23 835 USD
|
1 655
-2.8%
|
14,40
|
23 835 USD
|
|
|
2023-06-21 |
2023-06-16 |
V
Vente
|
Pitman Jama
See Remarks
Dirigeant
|
1 238
-2.7%
14,40
17 829 USD
|
1 238
-2.7%
|
14,40
|
17 829 USD
|
|
|
2023-06-12 |
2023-06-08 |
A
Achat
|
Friedman Franklin Stuart
Administrateur non-exécutif
|
10 000
+inf%
13,88
138 828 USD
|
10 000
+inf%
|
13,88
|
138 828 USD
|
|
|
2023-05-12 |
2023-05-10 |
A
Achat
|
Walsh Dennis Leo
Administrateur non-exécutif
|
11 000
+inf%
13,86
152 416 USD
|
11 000
+inf%
|
13,86
|
152 416 USD
|
|
|
2023-03-23 |
2023-03-21 |
VP
Vente planifiée
|
Hoerter Steven L.
President and CEO
Administrateur exécutif
|
7 500
-100.0%
15,57
116 782 USD
|
7 500
-100.0%
|
15,57
|
116 782 USD
|
|
|
2023-02-17 |
2023-02-16 |
V
Vente
|
Martin Daniel C.
Chief Commercial Officer
Dirigeant
|
1 159
-1.9%
15,10
17 500 USD
|
1 159
-1.9%
|
15,10
|
17 500 USD
|
|
|
2023-02-17 |
2023-02-16 |
V
Vente
|
Kelly Thomas Patrick
Chief Financial Officer
Dirigeant
|
1 370
-2.3%
15,10
20 686 USD
|
1 370
-2.3%
|
15,10
|
20 686 USD
|
|
|
2023-02-17 |
2023-02-16 |
V
Vente
|
Flynn Daniel Lee
Chief Scientific Officer
Dirigeant
|
1 370
-2.3%
15,10
20 686 USD
|
1 370
-2.3%
|
15,10
|
20 686 USD
|
|
|
2023-02-17 |
2023-02-16 |
V
Vente
|
Sherman Matthew L
EVP & Chief Medical Officer
Dirigeant
|
971
-1.1%
15,10
14 661 USD
|
971
-1.1%
|
15,10
|
14 661 USD
|
|
|
2023-02-17 |
2023-02-16 |
V
Vente
|
Pitman Jama
See Remarks
Dirigeant
|
1 159
-2.5%
15,10
17 500 USD
|
1 159
-2.5%
|
15,10
|
17 500 USD
|
|
|
2023-02-16 |
2023-02-14 |
VP
Vente planifiée
|
Hoerter Steven L.
President and CEO
Administrateur exécutif
|
30 045
-80.0%
16,00
480 720 USD
|
30 045
-80.0%
|
16,00
|
480 720 USD
|
|
|
2023-01-24 |
2023-01-24 |
A
Achat
|
Brightstar Associates LLC
Actionnaire important
|
1 666 666
+9.2%
18,00
29 999 988 USD
|
1 666 666
+9.2%
|
18,00
|
29 999 988 USD
|
|
|
2023-01-19 |
2023-01-17 |
VP
Vente planifiée
|
Sherman Matthew L
EVP & Chief Medical Officer
Dirigeant
|
2 403
-3.2%
21,24
51 043 USD
|
2 403
-3.2%
|
21,24
|
51 043 USD
|
|
|
2023-01-19 |
2023-01-17 |
VP
Vente planifiée
|
Martin Daniel C.
Chief Commercial Officer
Dirigeant
|
1 603
-3.2%
21,24
34 050 USD
|
1 603
-3.2%
|
21,24
|
34 050 USD
|
|
|
2023-01-19 |
2023-01-17 |
V
Vente
|
Kelly Thomas Patrick
Chief Financial Officer
Dirigeant
|
2 403
-5.2%
21,24
51 043 USD
|
2 403
-5.2%
|
21,24
|
51 043 USD
|
|
|
2023-01-19 |
2023-01-17 |
V
Vente
|
Pitman Jama
See Remarks
Dirigeant
|
1 603
-4.4%
21,24
34 050 USD
|
1 603
-4.4%
|
21,24
|
34 050 USD
|
|
|
2023-01-19 |
2023-01-17 |
V
Vente
|
Flynn Daniel Lee
Chief Scientific Officer
Dirigeant
|
2 403
-5.2%
21,24
51 043 USD
|
2 403
-5.2%
|
21,24
|
51 043 USD
|
|
|
2022-10-05 |
2022-10-03 |
V
Vente
|
Sherman Matthew L
EVP & Chief Medical Officer
Dirigeant
|
2 587
-3.4%
18,73
48 455 USD
|
2 587
-3.4%
|
18,73
|
48 455 USD
|
|
|
2022-06-21 |
2022-06-16 |
V
Vente
|
Kelly Thomas Patrick
Chief Financial Officer
Dirigeant
|
1 768
-3.7%
10,75
19 006 USD
|
1 768
-3.7%
|
10,75
|
19 006 USD
|
|
|
2022-06-21 |
2022-06-16 |
V
Vente
|
Flynn Daniel Lee
Chief Scientific Officer
Dirigeant
|
1 768
-3.7%
10,75
19 006 USD
|
1 768
-3.7%
|
10,75
|
19 006 USD
|
|
|
2022-06-21 |
2022-06-16 |
VP
Vente planifiée
|
Sherman Matthew L
EVP & Chief Medical Officer
Dirigeant
|
1 768
-2.2%
10,75
19 006 USD
|
1 768
-2.2%
|
10,75
|
19 006 USD
|
|
|
2022-06-21 |
2022-06-16 |
VP
Vente planifiée
|
Martin Daniel C.
Chief Commercial Officer
Dirigeant
|
1 311
-2.6%
10,75
14 093 USD
|
1 311
-2.6%
|
10,75
|
14 093 USD
|
|
|
2022-06-21 |
2022-06-16 |
V
Vente
|
Pitman Jama
See Remarks
Dirigeant
|
1 298
-3.4%
10,75
13 954 USD
|
1 298
-3.4%
|
10,75
|
13 954 USD
|
|
|
2022-04-29 |
2022-04-29 |
A
Achat
|
Brightstar Associates LLC
Actionnaire important
|
1 478 978
+8.9%
10,00
14 789 780 USD
|
1 478 978
+8.9%
|
10,00
|
14 789 780 USD
|
|
|
2022-02-18 |
2022-02-16 |
V
Vente
|
Sherman Matthew L
EVP & Chief Medical Officer
Dirigeant
|
984
-1.3%
9,05
8 905 USD
|
984
-1.3%
|
9,05
|
8 905 USD
|
|
|
2022-02-18 |
2022-02-16 |
V
Vente
|
Martin Daniel C.
Chief Commercial Officer
Dirigeant
|
1 146
-2.3%
9,05
10 371 USD
|
1 146
-2.3%
|
9,05
|
10 371 USD
|
|
|
2022-02-18 |
2022-02-16 |
V
Vente
|
Flynn Daniel Lee
Chief Scientific Officer
Dirigeant
|
1 366
-2.8%
9,05
12 362 USD
|
1 366
-2.8%
|
9,05
|
12 362 USD
|
|
|
2022-02-18 |
2022-02-16 |
V
Vente
|
Kelly Thomas Patrick
Chief Financial Officer
Dirigeant
|
1 368
-2.8%
9,05
12 380 USD
|
1 368
-2.8%
|
9,05
|
12 380 USD
|
|
|
2022-02-18 |
2022-02-16 |
V
Vente
|
Pitman Jama
See Remarks
Dirigeant
|
1 146
-2.9%
9,05
10 371 USD
|
1 146
-2.9%
|
9,05
|
10 371 USD
|
|
|
2021-10-06 |
2021-10-04 |
VP
Vente planifiée
|
Sherman Matthew L
EVP & Chief Medical Officer
Dirigeant
|
2 659
-5.5%
33,17
88 199 USD
|
2 659
-5.5%
|
33,17
|
88 199 USD
|
|
|
2021-05-05 |
2021-05-03 |
VP
Vente planifiée
|
Taylor Michael Douglas
Administrateur non-exécutif
|
300
-100.0%
46,75
14 025 USD
|
300
-100.0%
|
46,75
|
14 025 USD
|
|
|
2021-05-05 |
2021-05-03 |
VP
Vente planifiée
|
Taylor Michael Douglas
Administrateur non-exécutif
|
7 700
-96.2%
46,07
354 718 USD
|
7 700
-96.2%
|
46,07
|
354 718 USD
|
|
|
2021-04-21 |
2021-04-20 |
VP
Vente planifiée
|
Bristol James Arthur
Administrateur non-exécutif
|
1 700
-100.0%
45,60
77 514 USD
|
1 700
-100.0%
|
45,60
|
77 514 USD
|
|
|
2021-04-21 |
2021-04-19 |
VP
Vente planifiée
|
Bristol James Arthur
Administrateur non-exécutif
|
1 300
-100.0%
46,66
60 662 USD
|
1 300
-100.0%
|
46,66
|
60 662 USD
|
|
|
2021-04-21 |
2021-04-19 |
VP
Vente planifiée
|
Bristol James Arthur
Administrateur non-exécutif
|
4 000
-75.5%
46,13
184 518 USD
|
4 000
-75.5%
|
46,13
|
184 518 USD
|
|
|
2021-04-14 |
2021-04-12 |
VP
Vente planifiée
|
Bristol James Arthur
Administrateur non-exécutif
|
5 217
-100.0%
44,09
230 040 USD
|
5 217
-100.0%
|
44,09
|
230 040 USD
|
|
|
2021-04-14 |
2021-04-12 |
VP
Vente planifiée
|
Bristol James Arthur
Administrateur non-exécutif
|
9 483
-64.5%
43,70
414 370 USD
|
9 483
-64.5%
|
43,70
|
414 370 USD
|
|
|
2021-04-06 |
2021-04-01 |
VP
Vente planifiée
|
Taylor Michael Douglas
Administrateur non-exécutif
|
906
-100.0%
46,72
42 328 USD
|
906
-100.0%
|
46,72
|
42 328 USD
|
|
|
2021-04-06 |
2021-04-01 |
VP
Vente planifiée
|
Taylor Michael Douglas
Administrateur non-exécutif
|
4 994
-84.6%
45,69
228 169 USD
|
4 994
-84.6%
|
45,69
|
228 169 USD
|
|
|
2021-04-06 |
2021-04-01 |
VP
Vente planifiée
|
Taylor Michael Douglas
Administrateur non-exécutif
|
2 100
-26.2%
44,80
94 074 USD
|
2 100
-26.2%
|
44,80
|
94 074 USD
|
|
|
2021-03-03 |
2021-03-01 |
VP
Vente planifiée
|
Taylor Michael Douglas
Administrateur non-exécutif
|
1 104
-100.0%
44,68
49 324 USD
|
1 104
-100.0%
|
44,68
|
49 324 USD
|
|
|
2021-03-03 |
2021-03-01 |
VP
Vente planifiée
|
Taylor Michael Douglas
Administrateur non-exécutif
|
6 896
-86.2%
43,94
302 983 USD
|
6 896
-86.2%
|
43,94
|
302 983 USD
|
|
|
2021-02-18 |
2021-02-16 |
V
Vente
|
Sherman Matthew L
EVP & Chief Medical Officer
Dirigeant
|
132
-0.4%
48,87
6 451 USD
|
132
-0.4%
|
48,87
|
6 451 USD
|
|
|
2021-02-18 |
2021-02-16 |
V
Vente
|
Flynn Daniel Lee
Chief Scientific Officer
Dirigeant
|
508
-7.2%
48,87
24 826 USD
|
508
-7.2%
|
48,87
|
24 826 USD
|
|
|
2021-02-18 |
2021-02-16 |
V
Vente
|
Kelly Thomas Patrick
Chief Financial Officer
Dirigeant
|
524
-7.4%
48,87
25 608 USD
|
524
-7.4%
|
48,87
|
25 608 USD
|
|
|
2021-02-03 |
2021-02-01 |
VP
Vente planifiée
|
Taylor Michael Douglas
Administrateur non-exécutif
|
800
-100.0%
45,96
36 770 USD
|
800
-100.0%
|
45,96
|
36 770 USD
|
|
|
2021-02-03 |
2021-02-01 |
VP
Vente planifiée
|
Taylor Michael Douglas
Administrateur non-exécutif
|
4 518
-85.0%
45,64
206 188 USD
|
4 518
-85.0%
|
45,64
|
206 188 USD
|
|
|
2021-02-03 |
2021-02-01 |
VP
Vente planifiée
|
Taylor Michael Douglas
Administrateur non-exécutif
|
2 682
-33.5%
44,34
118 915 USD
|
2 682
-33.5%
|
44,34
|
118 915 USD
|
|
|
2021-01-20 |
2021-01-15 |
VP
Vente planifiée
|
Bristol James Arthur
Administrateur non-exécutif
|
600
-100.0%
51,11
30 666 USD
|
600
-100.0%
|
51,11
|
30 666 USD
|
|
|
2021-01-20 |
2021-01-15 |
VP
Vente planifiée
|
Bristol James Arthur
Administrateur non-exécutif
|
6 400
-91.4%
50,21
321 373 USD
|
6 400
-91.4%
|
50,21
|
321 373 USD
|
|
|
2021-01-06 |
2021-01-04 |
VP
Vente planifiée
|
Taylor Michael Douglas
Administrateur non-exécutif
|
2 794
-100.0%
57,37
160 294 USD
|
2 794
-100.0%
|
57,37
|
160 294 USD
|
|
|
2021-01-06 |
2021-01-04 |
VP
Vente planifiée
|
Taylor Michael Douglas
Administrateur non-exécutif
|
8 517
-75.3%
56,73
483 175 USD
|
8 517
-75.3%
|
56,73
|
483 175 USD
|
|
